CTOs on the Move

China Aoxing Pharmaceutical Company

www.chccgroup.com

 
China Aoxing Pharmaceutical Company is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.chccgroup.com
  • 444 Washington Blvd Apt 2424
    Jersey City, NJ USA 07310
  • Phone: 201.420.1075

Executives

Name Title Contact Details

Similar Companies

CBR International Corp

CBR International Corp is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grant Regional Health Center

Grant Regional Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Grant Regional Health Center is based in Lancaster, WI. You can find more information on Grant Regional Health Center at www.grantregional.com

Med USA

Med USA is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wisdo Health

Wisdo is an award-winning social health and clinical referral platform that addresses the adverse consequences of social isolation and loneliness on the mental and physical health of 124 million Americans. Research shows that Wisdo results in $1,900+ in annual medical cost savings, a 37% reduction in depression, a 34% increase in the number of healthy days experienced by our members, and an 80% retention rate on month 12. More than 1 million adults have joined the Wisdo community, where they realized measurable improvements in their health through community-driven social support, professionally moderated group sessions, and when appropriate clinical referrals based on predictive analytics.

Pacira Pharmaceuticals

Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company`s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.